Webinar

3D Printing in Hospitals

In recent years, many hospitals have started making a shift, from using medical images primarily for diagnostic purposes, to integrating them in patient-specific surgical planning. This has created enormous advantages for hospitals and their patients and is largely supported by the clarifying regulatory landscape, increased governmental support, new public and private initiatives, and the expanding role of the radiologist as an imaging expert. As part of this, an increasing number of hospitals across the world have integrated the practice of 3D printing into their medical care. Hospitals are recognizing the added value it brings to personalized patient care and the countless possibilities that are becoming a reality, in creating better treatment options.

Speakers:

Kerim Genc

blank

Kerim Genc is the Business Development Manager for the Simpleware Product Group at Synopsys.  He joined Simpleware in 2011 and is currently responsible for managing global sales, business development, partnerships and technical marketing content development, with a significant focus on image-based patient specific workflows for 3D Printing and surgical guides/planning.  He received his BS and MS in biomechanics from the University of Calgary and the Pennsylvania State University respectively, and completed his PhD in Biomedical Engineering at Case Western Reserve University, examining countermeasures to and computational models of spaceflight induced bone loss and fracture risk.

Shannon Walters

blank

Shannon Walters is an innovation enabler and workflow-optimization enthusiast. At Stanford 3D and Quantitative Imaging Lab, Shannon works closely with healthcare providers, researchers, and educators to enable effective health visualization. 

Recent innovations are of particular interest to Shannon such as 3D Printing, immersive volumetric visualization, and concise reporting of changes over time. 

Paul Fotheringham

blank

Paul Fotheringham is the founder of 3D LifePrints (3DLP) and is an experienced Technologist, Entrepreneur, and 3D printing expert who focuses on the medical sector. He holds a joint Bachelor of Science degree in Computer & Management Science from the University of Edinburgh. After graduating, he worked in over 10 countries including the US, UK, HK, Japan, and South Korea as an Enterprise Architect for organizations such as the London Stock Exchange, British Petroleum, Accenture and Macquarie Group. In 2012 he took up a post as Chief Technology Officer for a global Micro-finance organization in Kenya where he subsequently started 3DLP initially as a Social Enterprise in order to provide sustainable, affordable and suitable 3D printed prosthetics for developing world amputees. He currently overseas 3DLP’s European operations from Barcelona that provide a variety of innovative medical 3D printing products and services to medical institutions.

Albert Woo

blank

Albert S. Woo, MD, FACS is a board-certified plastic and reconstructive surgeon specializing in craniofacial surgery. This work has led to a particular interest in three dimensional imaging and printing of complex surgical models. He is an Associate Professor of Surgery, Pediatrics and Neurosurgery at The Warren Alpert Medical School of Brown University and serves as the Chief of the Division of Pediatric Plastic Surgery, Director of the Cleft and Craniofacial Center at Hasbro Children’s Hospital, and is the founding Director of the Lifespan 3D Printing Laboratory.

blank

3D Bioprinting for Food

Lately, 3D printing food has become a hot topic, as climate change and the impending water shortage crisis all beckon humanity for alternative more environmental (and healthier) food sources. “Cultured meat”, “cellular agriculture”, “lab-grown meats” are all new popular concepts that are receiving increasing attention. What are the roles of 3D printing in all this? What are the issues entrepreneurs and scientists facing? Who are the influencers, rising startups, regulatory bodies for this emerging field? How is the culinary world receiving the 3D printing concept? 

Speakers:

Avery Parkinson

blank

Avery is the Executive Director of Cellular Agriculture Canada. She has been passionate about cell ag technology for a couple of years now and has held positions at Tufts University, Big Idea Ventures, the Good Food Institute, and the Protein Report where she has worked on creating educational content and resources to grow the industry nationally and worldwide.

Kyle Von Hasseln

blank

Kyle von Hasseln is an American inventor, entrepreneur and adventurer. He graduated Middlebury College with a focus in molecular ecology. He was awarded the Frank Gehry Prize for Best Thesis at the Southern California Institute of Architecture, where he invented and patented the first dehydrated food 3D printer. His startup, Sugar Lab, was acquired by 3D Systems where he led the development of the first NSF certified commercial food 3D printer. In 2020 he founded Culinary Printworks, the first on-demand culinary 3D printing firm, and brought back the retail Sugar Lab brand. Kyle is an avid backcountry skier, surfer, and alpine rock climber.

Roger Kuan

blank

Roger Kuan is a Partner at Haynes and Boone and chair of the Precision Medicine and Digital Health Practice Group, where he counsels companies that are uniquely positioned in the convergence of the life/medical sciences and technology industries on how to successfully navigate the complexities of the intellectual property (IP), data rights and regulatory challenges they encounter.Roger has extensive experience in IP strategy and portfolio management (utility/design patents, trademarks, copyrights, and trade dress), data rights strategy, licensing and technology transactions, freedom-to-operate clearances, enforcement, monetization, IP due diligence, and dispute resolution. His practice is focused in the life sciences sector (e.g., research tools, analytical instrumentation/software, digital therapeutics, medical devices, diagnostics, biomanufacturing equipment, etc.) with an emphasis in emerging technologies such as Precision Medicine (e.g., genomic sequencing platforms, AI/ML, computational genomics/bioinformatics, molecular diagnostics, companion diagnostics, etc.), Digital Health (e.g., mobile apps, clinical decision support, software, digital therapeutics, AI/ML Imaging Diagnostics, wearables, etc.) and 3D printing/bioprinting. Prior to joining Haynes and Boone, Roger served as Director, IP Counsel at a multinational biotechnology company, where he managed a team to support the worldwide IP needs of the company’s life sciences tools, bioproduction/biomanufacturing, molecular diagnostics, and nucleic acid sequencing system/software platforms. Prior to finishing his law degree, he worked in the life sciences industry for several Fortune 500 pharmaceutical, medical device, and chemical companies. He has held professional positions in the R&D, sales, engineering, and regulatory affairs organizations.

Simon Fried

blank

Simon, head of business at MeaTech, grew up around restaurants, has business experience including food retail, FMCG, distilleries and 3D printing. Combined with his academic background in risk, behavioral economics, and behavior change, he’s excited to be playing a part in the cultivated meat transformation.

Moderator:

Dr. Vidya Chamundeswari Narasimhan

 3DHeals Community Manager – San Francisco

blank

Dr. Vidya is currently heading the Biomaterials engineering division at NEW AGE MEATS – Berkeley, California. She received her Ph.D from Nanyang Technological University(NTU), Singapore in 2018. Her research focused on developing bioactive polymeric scaffolds for musculoskeletal tissue regeneration applications.

During her post doctoral fellowship in Singapore, Vidya spearheaded various academia-industrial collaborative projects. At 3DHEALS, she is our Community Manager of San Francisco Bay Area and is also actively involved in STEM mentorship and in tutoring University and Junior college students for various competitive examinations.  

Vidya has been actively involved in research pertaining to sustainability within the agro-food and biomaterials sector, and is passionate about emerging technologies in the field of 3D bioprinting. She hopes to actively share and spread this interest amongst like minded professionals in the field of  regenerative medicine and tissue engineering. Currently Vidya has contributed to a couple of expert column blogs on bone tissue engineering and is the co-instructor of an online course on Bioinks used for Bioprinting available on Udemy!

blank

3D Printing in Orthopedics

In this virtual event focusing on 3D printing in Orthopedics, we feature a panel of international influencers, rising startups, and hot topics to both learn and discuss what innovators and entrepreneurs are experiencing from their personal perspectives, ranging from metal 3D printing, implants, to various other 3D technologies that are related to 3D printing surgical planning tools, such as AR/VR/MR. Through the conversation, we hope to learn more about current industry landscape and trends.

Speakers:

Dr. Alan Dang

blank

Dr. Alan Dang is a board-certified, licensed orthopaedic spine surgeon. He is an HS Clinical Associate Professor at UCSF. Along with his brother, Dr. Alexis Dang, he started the Orthopaedic Rapid Intelligent Fabrication (ORIF) program at UCSF/San Francisco VA and is a founding member of the UCSF Center for Applied 3D+ Technologies. Dr. Dang is also a capstone mentor and member of the selection committee for the UCSF/UC Berkeley Masters in Translational Medicine program.

Brian McLaughlin

blank

Brian is the founder of Amplify Additive. He is passionate about orthopedics and is well-versed in all aspects of advanced manufacturing – from the industry’s leading innovators and product development to commercialization strategies and business trends. Creative and entrepreneurial by nature, Brian’s attention is on identifying opportunities for new business development in existing and emerging orthopedic markets, and in assisting companies looking to leverage AM technology.

Brian and his team at Amplify are focused on advancing Additive Manufacturing for Orthopedics, utilizing GE Additive’s Arcam Electron Beam Melting (EBM) technology for innovative implant solutions across all indications. Brian has experience across all industry lines in the orthopedic market including design & manufacturing for a leading CMO; as a clinical specialist working directly with surgeons; as the VP of Engineering and co-founder of a Foot & Ankle implant company leveraging AM for implants; and now as the leader at Amplify Additive.  Brian has a BS in Biomedical Engineering from the University of Vermont.  

Brian lives in Yarmouth, ME with his wife and two sons. In addition to his passion for the orthopedic market, he enjoys playing and coaching soccer, alpine skiing, cycling, running and occasionally golfing.

Interview with Dr. Alan Dang, co-Founder of PrinterPrezz

Dr. Bruno Gobbato

blank

Dr. Gobbato is an orthopedic surgeon and specialist in the anatomy of shoulders and elbows. He has been a part of 3D printing in medicine and orthopedic models since 2013. Works with mixed reality and Artificial Intelligence. 

Interview with Dr. Bruno Gobbato: 3D Printing Orthopedics

Dr. Richard Hurley

blank

Dr. Richard Hurley is an orthopaedic surgeon with over a decade of experience in medical 3D printing. He is an assistant professor at Dalhousie University in Halifax, Nova Scotia specialising in hip and knee replacement surgery. In 2012 he co-founded Conceptualiz to provide easy to use virtual surgical planning and medical 3D printing software to healthcare providers. He is the director of the in-hospital medical 3D printing lab at the Dartmouth General Hospital. He is also the curator of the 3D Orthopaedic Special Interest Group (3DOS) and was a former computer assisted surgery product manager for DePuy Canada.

Moderator:

Dr. Nathan J. Castro

blank

Dr. Nathan J. Castro is an experienced biomedical researcher and entrepreneur.  He has assisted in the design, testing, regulatory approval and clinical translation of 3D printed medical devices, as well as co-founded Nanochon, Inc.  He is skilled in policy analysis, life sciences, data analysis, and quantitative research with particular interest in clinical translational (bench-to-bedside).  With domestic and international research appointments at well-recognized laboratories, Dr. Castro is always in search of opportunities to leave a positive impact on whomever he has the pleasure of working with.

blank

The Legal Landscape in Healthcare 3D Printing

It is our experience that risk can be mitigated with knowledge. In the upcoming months, we plan to invite legal and regulatory experts to provide foundation knowledge and updates on the legal landscape in healthcare 3D printing. These webinars will focus on critical issues faced by entrepreneurs and startups in the healthcare 3D printing ecosystem, ranging from intellectual property, medical device liability, as well as FDA and CE regulations and guidance, focusing both on biological and non biological devices.

Speakers:

Sean Burke

Sean Burke profile

Sean Burke is partner and vice chair of the products liability trial division at Duane Morris. He is in the firm’s Washington, DC office.  Mr. Burke’s practice focuses on representation of manufacturers of medical devices in products liability cases across the country, including in consolidated multi-plaintiff matters in both federal court and state courts. His experience includes defense of large total joint replacements (hips, knees, ankles, and shoulders) and resurfacings, tissue matrices and patches, fusion plates, and surgical instruments.  He has a particular interest and focus on additive manufacturing, consulting and advising clients on best practices in the early stages of development to reduce risk of products liability exposure.  He has tried medical device cases before juries in both state and federal courts while also handling numerous mediations.  He works closely with scientific experts to advance causation and liability defenses in the areas of biomechanical engineering, toxicology, histology, epidemiology, orthopedic surgery and FDA regulations.

Roger Kuan

blank

Roger Kuan is a Partner at Haynes and Boone and chair of the Precision Medicine and Digital Health Practice Group, where he counsels companies that are uniquely positioned in the convergence of the life/medical sciences and technology industries on how to successfully navigate the complexities of the intellectual property (IP), data rights and regulatory challenges they encounter.Roger has extensive experience in IP strategy and portfolio management (utility/design patents, trademarks, copyrights, and trade dress), data rights strategy, licensing and technology transactions, freedom-to-operate clearances, enforcement, monetization, IP due diligence, and dispute resolution. His practice is focused in the life sciences sector (e.g., research tools, analytical instrumentation/software, digital therapeutics, medical devices, diagnostics, biomanufacturing equipment, etc.) with an emphasis in emerging technologies such as Precision Medicine (e.g., genomic sequencing platforms, AI/ML, computational genomics/bioinformatics, molecular diagnostics, companion diagnostics, etc.), Digital Health (e.g., mobile apps, clinical decision support, software, digital therapeutics, AI/ML Imaging Diagnostics, wearables, etc.) and 3D printing/bioprinting. Prior to joining Haynes and Boone, Roger served as Director, IP Counsel at a multinational biotechnology company, where he managed a team to support the worldwide IP needs of the company’s life sciences tools, bioproduction/biomanufacturing, molecular diagnostics, and nucleic acid sequencing system/software platforms. Prior to finishing his law degree, he worked in the life sciences industry for several Fortune 500 pharmaceutical, medical device, and chemical companies. He has held professional positions in the R&D, sales, engineering, and regulatory affairs organizations.

Dr. Jenny Chen

jenny chen

Dr. Jenny Chen is trained as a neuroradiologist, founder/CEO of 3DHEALS. Her main interests include medical education, 3D printing in the healthcare sector, and artificial intelligence. She is also a current adjunct clinical faculty in the radiology department at Stanford Healthcare.

blank

3D Bioprinting Vasculatures

3D bioprinting vasculatures is perhaps the holy grail of the next industrial revolution in healthcare. Biofabrication and bioprinting of any viable three-dimensional tissue will not be successful unless the vascularization challenge has been solved. Many organizations and talents around the world are actively tackling this challenge, but where are we exactly?

Speakers:

Andrew Hudson

blank

Andrew received his B.Sc. in Materials Science and Engineering (2014) and M.Sc. in Biomedical Engineering (2015) from Carnegie Mellon University. He is currently a Ph.D. student in Adam Feinberg’s Regenerative Biomaterials and Therapeutics Group. The goal of Andrew’s research is to vastly improve the resolution and vascularization in 3D bioprinting to create the next generation of tissue engineered therapies such as cardiac muscle. Andrew is also a Co-Founder of FluidForm, a CMU startup that seeks to spread the FRESH 3D bioprinting technology developed in the Feinberg lab. 

Jordan Miller

blank

Jordan Miller is an Associate Professor of Bioengineering. at Rice University and Co-Founder of Volumetric, a Houston-based startup focused on next-generation biomaterials and biofabrication technologies. Miller received his bachelor’s degree in Biology from MIT in 2003 and earned his Ph.D. in Bioengineering from Rice University in 2008. His primary interests combine synthetic chemistry, 3D printing, microfabrication, and molecular imaging to direct cultured human cells to form more complex organizations of living vessels and tissues for research in regenerative medicine. Precisely engineered in vitro systems at the molecular, micro- and meso-scale are well suited to decouple the relationship between tissue architecture and cell function. These systems are now permitting comprehensive closed-loop design and optimization of large-scale engineered tissues through refinement with computer models of mass transport and assessment of their therapeutic potential in vivo.

Prafulla Chandra

blank

Dr. Prafulla Chandra is an accomplished life science professional with current specialization in regenerative medicine, 3D bioprinting, and cell biology. He has a Ph.D. in Biotechnology from the University of Pune (India), and more than 16 years of combined scientific research experience. His unique combination of skills and experience include research, technology development and intellectual property related to biomedical and regenerative medicine products. Dr. Chandra has been working at the Wake Forest Institute for Regenerative Medicine (WFIRM) since the past 7 years under the mentorship of Dr. Anthony Atala, where his work in 3D bioprinting includes using extrusion and ink-jet based bioprinters for creating live tissues such as cartilage, bone, skin, urethra and many types of polymer scaffolds for tissue regeneration and diagnostic applications such dermal scaffolds, microfluidics-based cell culture and organ-on-a-chip systems. Additionally, adapting synthetic polymers for 3D bioprinting, creating self-expanding polymers, bioink development, stem-cells based therapies and organ-on-a-chip for screening and diagnostic applications are his other projects at WFIRM. In association with the Regenerative Medicine Clinical Center (RMCC) at WFIRM, Dr. Chandra has also worked on clinical translation of regenerative medicine products, which include an oxygen-generating wound dressing and a 3D bioprinted nasal septum cartilage. He was a core team member for validating a 3D bioprinter for clinical manufacturing and also participated in the writing of regulatory documents such as pre-IND and IND for submission to the US FDA. Prior to joining WFIRM, Dr. Chandra had worked at the New Jersey Center for Biomaterials (under the mentorship of Prof. Joachim Kohn, Director, New Jersey Center for Biomaterials, Rutgers University, NJ, USA), where his work included research in the fields of cell-biomaterial interactions, human skin tissue engineering, surface modification of polymers for enhancing cellular response and using synthetic polymer-based nanospheres for enhancing topical delivery of hydrophobic drugs. One of his research here led to the award of a US Patent (Patent No. 8414871) on which he is a co-inventor.

James (Jay) Hoying, Ph.D.

blank

James (Jay) Hoying, Ph.D. is Partner and Chief Scientist of Advanced Solutions Life Sciences (ASLS), a company pioneering solutions in tissue fabrication and biomanufacturing. Prior to joining ASLS, Dr. Hoying was the Chief of the Division of Cardiovascular Therapeutics at the Cardiovascular Innovation Institute (CII) and a Professor in the Department of Physiology at the University of Louisville. He has over 25 years of experience in basic and applied biological sciences research with a focus in tissue biology, tissue vascularization, and the microcirculation. In addition to his numerous published works, Dr. Hoying holds patents related to vascularizing tissues and related cell-based therapies; technologies that have been translated to companies, including start-ups and ASLS. Dr. Hoying is a Fellow of the American Heart Association.

Moderator:

Lehanna N. Sanders, PhD

Business Development Manager, Advanced Solutions Life Sciences

blank

Dr. Lehanna Sanders is a cellular and molecular biologist and has done research within the field of regenerative medicine for 8 years.  She received her Bachelor’s degree in Cellular, Molecular, and Development Biology from Purdue University where she completed an honors thesis project in Biomedical Engineering.  She then completed her PhD at Vanderbilt University where she published work in the area of molecular repair processes following acute cardiac injury.  During her time at Vanderbilt, she served on the Skills Development Committee for the NHLBI Progenitor Cell Biology Consortium, as well as a member of the Board of the Directors for the Life Science Tennessee-Academic Alliance.  She now works in Business Development for Advanced Solutions Life Sciences, where she is continuing to grow the field of regenerative biology through working closely with scientists and engineers to advance innovations in 3D bioprinting and biofabrication.

Point of Care 3D Printing July 15

Point of Care 3D Printing

Point of care 3D printing is becoming one of the biggest attractions in adopting 3D printing in healthcare systems because it demonstrates the ability to decentralize manufacturing personalized medical devices. The medical devices can range from anatomical modeling, implants, to surgical guides based on the latest updates from all over the world. However, for companies interested in expanding markets either locally or regionally, understanding the complex relationships among different players and regulations are critical. In this webinar, we invited an international panel of experts who had both clinical and industrial experiences in point of care 3D printing to have an exciting conversation that we have all been waiting for.

Speakers:

Andrew Woodward

blank

Andrew has been working in medical imaging for 38 years and holds ARRT certifications in Radiography, Computed Tomography and Quality Management. After 30 years of teaching medical imaging, Andrew retired to join the Advanced Medical Imaging Lab (AMIL) at The University of North Carolina Medical Center in 2106. His experience in education, radiography, vascular interventional radiology, cardiac catheterization and computed tomography added a new perspective on how to expand the AMIL’s services.  In 2017, Andrew provided proof of concept 3D printed models to his superiors and suggested that they implement a Point of Care 3D printing program that would be an integral part the image post-processing the AMIL was currently performing. The idea was well received and he began the process of procuring software and 3D printers to start production of models for patient education and surgical planning. Currently, the AMIL utilizes Mimics inPrint™ for creating the model files and the following printers: three Ultimaker S5; one Ultimaker 3 Extended and a Form3.  Andrew has created models for complex pediatric spinal deformities; pediatric congenital heart defects, adult congenital heart disease, maxillofacial reconstruction and numerous orthopedic models for complex surgical cases. He is also involved in variety of research projects investigating the use of 3D printing of models for surgical training.

Martin Herzmann

blank

Martin Herzmann started his medtech career in 1999 at Brainlab and was responsible for preoperative planning software. In 2007 he joined Ziehm Imaging and worked for another eight years as Marketing Director for medical capital equipment. In 2015, he joined the Materialise Medical division as Sales Manager and was responsible for German-speaking installations of planning software and services for medical 3D printing.

Since 2019, Martin Herzmann has been working as Business Development Manager at Kumovis. The company focuses on medical 3D printing with high-performance polymers and biodegradable polymers and launched the R1 3D printer in summer 2019: a system for additive manufacturing exclusively in medical technology. Customers include both hospitals and medical technology companies.

Paul Fotheringham

blank

Paul Fotheringham is the founder of 3D LifePrints (3DLP) and is an experienced Technologist, Entrepreneur, and 3D printing expert who focuses on the medical sector. He holds a joint Bachelor of Science degree in Computer & Management Science from the University of Edinburgh. After graduating, he worked in over 10 countries including the US, UK, HK, Japan, and South Korea as an Enterprise Architect for organizations such as the London Stock Exchange, British Petroleum, Accenture and Macquarie Group. In 2012 he took up a post as Chief Technology Officer for a global Micro-finance organization in Kenya where he subsequently started 3DLP initially as a Social Enterprise in order to provide sustainable, affordable and suitable 3D printed prosthetics for developing world amputees. He currently overseas 3DLP’s European operations from Barcelona that provide a variety of innovative medical 3D printing products and services to medical institutions.

Daniel Crawford

blank

Daniel Crawford is the Founder & Chief Strategy Officer of axial3D, a company creating automated solutions to make patient specific surgery routine practice in hospitals globally. Daniel graduated with a BSc Hons in Biomedical Engineering and an MSc in Medical Visualisation and Human Anatomy. He has over 10 years experience in medical device development and deployment into clinical settings, 7 of which are specifically related to medical 3D printing and automated applications. Daniel is responsible for the strategy within Axial3D, including its machine learning algorithms for use in creating 3D printed models from 2D medical scans.

Moderator:

Hannah Riedle

blank

Hannah studied Mechanical Engineer at the Technical University of Munich, where she specialized in medical technology. During her following Ph.D. at the Friedrich-Alexander-University Erlangen-Nuremberg, her research focused on the creation of digital anatomical models, additive manufacturing thereof, and as well as biomechanical and medical testing. From the topic of her Ph.D., she derived a business model which resulted in the foundation of ANAMOS in July 2020, where she is now responsible for the operational business as well as the technical development. Hannah has been the Munich-based 3DHEALS community manager since June 2017.

blank

3D Bioprinting Bone

Why is 3D bioprinting bone so important? Because the autologous bone graft is simply not enough. What many people perhaps don’t know is that bone harvesting is not only limited by donor sites and but also adding additional risk to surgeries. Just imagine patients with head and neck (or other) cancers, in addition to the wrath of cancer, they have to endure disfiguring but life-saving surgeries. Therefore, being able to use tissue engineering, digital design, 3D printing to create space-filling fully implantable bone tissue is many surgeons’ dream. However, what appears hard and homogenous, an ideal for 3D printing, is not easy, because the musculoskeletal system is actually a dynamic, ever-changing vascularized organ. Therefore, bioprinting bone faces many similar challenges to bioprinting other organ systems. In this webinar, we have included world-class scientists and entrepreneurs to share their latest discoveries and entrepreneurial journeys. 

Speakers:

Brian McKellar

Brian McKellar

Brian is the manufacturing manager at EpiBone Inc, a biotech start-up seeking to transform skeletal repair. Since joining in 2015, Brian has progressed the development of EpiBone’s products and is now leading the Phase I/II clinical manufacturing of EpiBone’s tissue-engineered anatomical bone graft. Brian received his MS/BS in Biomedical Engineering from Pennsylvania State University.

Casper Slots

blank

Casper Slots has research experience in materials science and development, tissue engineering and drug delivery – all in the fields of 3D printing. He has spent the last five years developing new 3D printable biological inks and drug delivery systems. He is a registered nurse with clinical experience and has extensive experience working with materials scientists, as well as with patients, clinicians, and surgeons. Casper is the Chief Commercial Officer of Particle3D where he oversees the development and commercial strategies of the company. Casper holds an MSc (Eng.) in Health & Welfare Technology, a BSc in Nursing, and is a TEDx speaker.

Ibrahim Tarik Ozbolat

Ibrahim Tarik Ozbolat

Ibrahim Tarik Ozbolat is an Associate Professor of Engineering Science and Mechanics, Biomedical Engineering and Neurosurgery, and a member of the Huck Institutes of the Life Sciences at Penn State University. Dr. Ozbolat’s main area of research is in the field of 3D Bioprinting. He has been working on several aspects of bioprinting such as bioprinting processes, bioink materials, bioprinters and post-bioprinting tissue maturation for manufacturing of more than a dozen tissues and organs. Dr. Ozbolat is a leading scientist with over 140 publications, including a sole-authored book in his domain. Due to his notable contributions to the field of bioprinting, he has received several prestigious international and national awards including 2014 NSF CAREER Award, 2014 SME Outstanding Young Manufacturing Engineer Award, 2014 ASME Chao and Trigger Young Manufacturing Engineer Award, 2014 ASME Tau Pi Sigma Gold Medal, 2015 IIE Dr. Hamid K. Eldin Outstanding Early Career Industrial Engineer in Academia Award, 2015 International Outstanding Young Researcher in Freeform and Additive Manufacturing Award and 2017 Hartz Family Career Development Professorship at Penn State.

Caralynn Nowinski Collens

blank

Dr. Caralynn Nowinski Collens is the CEO and co-founder of Dimension Inx, a regenerative biomaterials platform developing medical products that repair tissues and organs. She is passionate about building teams and organizations that harness technology to drive transformational change and improve the quality of people’s lives. Previously as the co-founder of UI LABS, a first-of-its-kind technology organization focused on the digital future of industries, Caralynn built the organization from concept in late 2011 through launch in 2014, serving as CEO until 2019. After starting her first company while a joint medical/business student at the University of Illinois at Chicago, Caralynn spent her early career in venture capital and corporate finance, primarily focused on technology-based university spin-outs. Caralynn is proud to have been a member of the Chicago Chapter of the Young Presidents’ Organization (YPO) and recognized as one of Crain’s Chicago Business’ “Forty Under Forty”, “Notable Women in Manufacturing”, and “Tech 50”.

Moderator: 

Joe Borrello

blank

Joe is currently a biomedical engineer and PhD Candidate at Mount Sinai, working in the labs of Drs.Kevin Costa and Junqian Xu, in addition to being the lead engineer with the Sinai BioDesign innovation team and helping run the MSIG and GRO-Biotech student groups. Previously, he worked at 3D Systemson technical development in the consumer marketing department and as a liaison with engineering project management teams, in addition to an earlier stint at experiential marketing firm Affinitive.

Joe received his bachelors in Biomedical Engineering from Macaulay Honors College at The City College of New York, where he also remains active in the Zahn Innovation Center, an on-campus tech startup incubator.He has also been involved in several startup ventures in the hardware and biotech spaces. Several years ago, Joe took Proto-Sauce, through NYCEDC’s Futureworks Incubator, with the goal of developing new materials for resin-based 3D printing. More recently, he had the privilege to serve as the CTO of BioSapien, using advanced manufacturing to create new devices for the treatment of cancer. Beyond Joe’s direct startup work, he has also continued to participate in Futureworks and other New York City startup programs as a mentor.

bioinks

The Art and Science of Bioinks

What is the secret sauce for successful bioprinting? It is well known that additive manufacturing biological materials, functional tissues, or even organs will rely heavily on the chemical and mechanical properties of the bioinks. While this is an area of active research, the perfect recipe to increase cell viability, biomimicry mechanical properties, and eventual tissue function is still elusive to many. Join us for this 90 minutes virtual event with world-class scientists and entrepreneurs to learn the basics and deep dive into the art and sciences of bioinks.

Speakers:

Stephanie Willerth

blank

Dr. Willerth holds a Canada Research Chair in Biomedical Engineering at the University of Victoria where she has dual appointments in the Department of Mechanical Engineering and the Division of Medical Sciences as an Associate Professor.

She serves as the Acting Director for the Centre for Biomedical Research at the University of Victoria and on the steering committee of the B.C. Regenerative Medicine Initiative. She also served as the President of the Canadian Biomaterials Society from 2017-2018. Her honors include being named the 2018 REACH award winner for Excellence in Undergraduate Research-inspired Teaching, a Woman of Innovation in 2017, one of the 2015 Young Innovators in Cellular and Biological Engineering and a “Star in Global Health” by Grand Challenges Canada in 2014.  She spent Fall of 2016 on sabbatical at the Wisconsin Institute for Discovery supported by the International Collaboration on Repair Discoveries International Travel Award where she wrote her book “Engineering neural tissue using stem cells” published by Academic Press.

She completed her postdoctoral work at the University of California-Berkeley after receiving her Ph.D. in Biomedical Engineering from Washington University. Her undergraduate degrees were in Biology and Chemical Engineering from the Massachusetts Institute of Technology.

Bowman Bagley

blank

Bowman Bagley has a B.S. in Neuroscience from Brigham Young University and an MBA from the University of Utah. He currently is a co-owner of Advanced BioMatrix, where he has developed, manufactured and launched over 50 products related to tunable substrate stiffness. He has also helped write multiple white papers related to various collagen properties and characteristics, including viscosity, rheology, purity, osmolality, pH, concentration and electrophoresis. Away from work, he is a husband, father, and avid rock climber. 

Ali Khademhosseini

blank

Ali Khademhosseini is currently the CEO and Founding Director at the Terasaki Institute for Biomedical Innovation. Previously, he was a Professor of Bioengineering, Chemical Engineering and Radiology at the University of California-Los Angeles (UCLA). He joined UCLA as the Levi Knight Chair in November 2017 from Harvard University where he was Professor at Harvard Medical School (HMS) and faculty at the Harvard-MIT’s Division of Health Sciences and Technology (HST), Brigham and Women’s Hospital (BWH) and as well as associate faculty at the Wyss Institute for Biologically Inspired Engineering. At Harvard University, he directed the Biomaterials Innovation Research Center (BIRC) a leading initiative in making engineered biomedical materials. Dr. Khademhosseini is an Associate Editor for ACS Nano. He served as the Research Highlights editor for Lab on a Chip. He is a fellow of the American Institute of Medical and Biological Engineering (AIMBE), Biomedical Engineering Society (BMES), Royal Society of Chemistry (RSC), Biomaterials Science and Engineering (FBSE), Materials Research Society (MRS), NANOSMAT Society, and American Association for the Advancement of Science (AAAS).  He is also the recipient of the Mustafa Prize ($500,000 prize) and is a member of the International Academy of Medical and Biological Engineering, Royal Society of Canada and Canadian Academy of Engineering, and National Academy of Inventors. He is an author on >650 peer-reviewed journal articles, editorials and review papers, >70 book chapters/edited books and >40 patents/patent applications. He has been cited >74,000 times and has an H-index of 139. He has made seminal contributions to modifying hydrogels and developing novel biomaterial solutions for addressing pressing problems in healthcare. He has founded 2 companies, Obsidio Medical and Bioray. He received his Ph.D. in bioengineering from MIT (2005), and MASc (2001) and BASc (1999) degrees from University of Toronto both in chemical engineering.

Moderator:

Jenny Chen, MD

jenny chen

Jenny Chen, MD, is currently the Founder and CEO of 3DHEALS, a company focusing on education and industrial research in the space of bioprinting, regenerative medicine, healthcare applications using 3D printing. With a focus on emerging healthcare technology, Jenny invests in and mentors relevant startups, especially companies pitching through Pitch3D. She believes a more decentralized and personalized healthcare delivery system will better our future.

blank

3D Printed Orthotics and Prosthetics

One of the very first healthcare applications using 3D printing is orthotics and prosthetics. Over the years, the images of disabled children with colorful prosthetic limbs inspired impactful movements like the ENABLE community and Victoria Hand Project, as well as enumerable passionate innovators who have pushed the boundaries to increase accessibility and lower the cost of orthotics and prosthetics. However, the field of 3D printed orthotics and prosthetics has advanced significantly since the days of ENABLE hands. These advancements include not just hardware, materials, but also software, designs, 3D scanning. More importantly, there is now a significant understanding of the importance of working closely with clinicians to create a more efficient digital workflow and more evidence-based patient-centered clinical solution. In this highly anticipated webinar, we invited experts with decades of technical, business, and clinical experiences and diverse perspectives to give the attendees a 360-degree view of the current and future status of the industry.

Speakers:

Brent Wright

blank

W. Brent Wright is an ABC-Certified Prosthetist and BOC-Certified Orthotist with Eastpoint Prosthetics and Orthotics in Raleigh, NC.  He has been in the field since he started as a technician at age 16 and has seen first hand how additive technology is evolving and impacts patients not only in the US but also in the developing world. 

Brent is pioneering techniques to effectively use additive technology such as MultiJet Fusion and Selective Laser Sintering to create dynamic prostheses that are light as well as flexible.  He is excited that prosthetists have a chance to be a part of the industrial revolution where mass customization and patient outcomes collide.  

Brent is the Clinical Director of LifeNabled, a non-profit that specializes in manufacturing all new low-cost and high quality prostheses.  LifeNabled has developed a scanning app for the iPad and iPhone called Digiscan3D and also has developed a suitcase 3D printer that can be deployed anywhere in the world.

Jordi Tura

blank

CEO & founder of Xkelet, more than 15 years in 3D design, printing, and software development.

Xkelet is a Machine Learning software company. With the software (the core of the Co.) we are able to automate the entire process, from data recording to the finished product. Currently. We have done a turnkey solution* in the category of Orthopedics and Prosthetics (O&P). We want to change the current immobilization methods such as plaster and current orthotic systems, to solve the problems that come from these immobilization systems.

The immobilizations are printed with 3D printing technology and suitable for accurate measurements of the patient’s anatomy.

With Xkelet, the patient can shower and dry without problems, no longer scratching due to scaling of the skin, in case the injury includes a wound already well derived by the fracture itself as an operative process, the patient and the medical professional can see the condition of the wound instantly thanks to the design of windows. And so I do not have to wait to have a feverish process or pain, for the traumatologist to remove the cast and see what the problem is. Usually with an unfavorable state of the most advanced recovery.

Tim Fair

blank

Tim Fair is a FL Licensed and ABC Certified Prosthetist Orthotist and academic chair for the A.S. O&P Technology program at St Petersburg College.  He earned his master’s degree of Instructional Design and Technology in 2016, his bachelor’s degree in Orthotics & Prosthetics in 2006 from UTSouthwestern.  He has been actively involved in O&P Technician, Pedorthic, and Orthotic Fitter education since his arrival at St Petersburg College.  His current focus is on orthotic fabrication classes for O&P technician students.

Jorge Zuniga

blank

Dr. Zuniga is the co-director of the Center for Biomechanical Rehabilitation and Manufacturing (CBRM) at the University of Nebraska at Omaha. The mission of our center is to improve the quality of life of medically underserved populations through the offering of comprehensive rehabilitation services and the creation of low-cost medical devices for our local, national, and international communities.

Moderator: 

Jordan Elevons

blank

Jordan Pelovitz is a 3D computer graphics artist and industrial design designer, with a BFA in Industrial. He has taught 3d printing and design to the public for over five years, both locally and internationally. Throughout his career, he has worked on a variety of design applications, from automotive to aerospace, and has used a unique blend of software to accelerate innovation in both the physical and digital worlds.
To this end, he has explored techniques for developing implants using game art tools, new 3d segmentation techniques and is currently developing a low-cost, 3d printed prosthetic toolchain for manufacturing in underserved areas.